|
|
|
| I. Itroduction |
 |
| |
|
| 1- Opening |
|
| |
|
| · Welcoming Address |
|
| H.E. Dr. Mansoor Ibrahim AI-Turki, President, King Saud University |
|
| |
|
|
· Introduction |
|
| Abdullah A. AI-Dadr, Dean, College of Pharmacy |
|
| |
|
| · Inaugural Speech |
|
| H.E. Dr. Hussein A. Jezairy, Minister of Health |
|
| |
|
| II. Pharmaceuticals in Developing Countries View Points |
|
| Moderator: Abdullah A. AI-Dadr |
|
| |
|
| III. Natural Sources or Medicinals |
|
| Moderator: Varro E. Tyler |
|
| |
|
| 2- Recent Advances in The Production of Pharmaceuticals by Utilizing Biotechnology and Plant Tissue Culture Systems. |
|
| E. John Staba |
|
| |
|
| 3- Marine Sources of Medicinals |
|
| Robert J. Wells |
|
| |
|
| 4- Medicinal Plants of Saudi Arabia. |
|
| Farid J. AI-Muhtadi |
|
| |
|
| 5- Utilization of Galenicals. |
|
| Valclemar H. Madis and V oIdemar Madis |
|
| |
|
| 6- Panel discussion |
|
| |
|
| IV. Manufacture of Pharmaceuticals |
|
| Moderator: Lawrence C. Weaver |
|
| |
|
| 7- Arab Pharmaceutical Industry: Present and Future. |
|
| Hashim A. Dhahir |
|
| |
|
| 8- Pharmaceutical Industry in Syria between Good Manufacturing Practice and Drug Consumption |
|
| M. Nezar Khawam |
|
| |
|
| 9- Panel discussion |
|
| |
|
| V. Quality Control of Pharmaceuticals |
|
| Moderator: Joseph V. Swintosky |
|
| |
|
| 10- Quality Control of Pharmaceuticals: Moderator's Remarks. |
|
| Joseph V. Swintosky |
|
| |
|
| 11- Developing A National Quality Control Program. |
|
| George H. Schneller |
|
| |
|
| 12-Developing A National Quality Control Program in Kuwait. |
|
| Ali Kassim |
|
| |
|
| 13- Requirements of Developing Countries from Pharmaceuticals. |
|
| Salim A. Babhair |
|
| |
|
| 14- Quality Assurance - An Integral Part of Pharmaceutical Service. |
|
| Archibald M.S. Cullen |
|
| |
|
| VI. Drug Delivery Systems and Quality Assurance |
|
| Moderator: Hassan Abdine |
|
| |
|
| 15- Recent Trends in Drug Development and Drug Delivery. |
|
| Anwar Hussain |
|
| |
|
| 16- Application of Instrumental Analysis in Drug Quality Assurance. |
|
| Mahmoud M.A. Hassan |
|
| |
|
| 17- New Approach in Plasma Fractionation. |
|
| R. Lissner and W. Stephan |
|
| |
|
| VII. Drugs: Risk vs Benefits |
|
| Moderator: Mohammed K. Boukaf |
|
| |
|
| 18- Drugs and Other Measures in Schistosomiasis Control in Saudi Arabia. |
|
| Samer S. Islam |
|
| |
|
| 19- Bis (Dioxopiperazines): Investigation of Their Stereo-Selective Effects on Metastases and Amelioration of Anthracyclin-Induced Toxicity. |
|
| Donald T. Witiak |
|
| |
|
| 20- Disease-Causing Drugs in The Developing Countries. |
|
| Abdelrahim EI-Sayed All |
|
| |
|
| VIII. Drugs: Tapping New Sources |
|
| Moderator: Peter A. Parish |
|
| |
|
| 21- Chronotherapy and Patient Care. |
|
| Hugh F. Kabat |
|
| |
|
| 22- Pyridylhaloalkylamines: Synthesis and Structure-Activity Relationships. |
|
| Mubarak A. Karrar |
|
| |
|
| 23- The Potential of Higher Plants and Marine Organisms As A Source of New Pharmaceuticals |
|
| Varro E. Tyler, John M. Cassady and Mikhail Antoun |
|
| |
|
| 24- The Present Status of Research on Medicinal Plants in Sudan. |
|
| Yabia M. El-Kbair |
|
| |
|
| IX. Summary and Recommendations |
|